PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.87%
Net income growth under 50% of CRWD's 30.05%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
19.27%
D&A growth well above CRWD's 6.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-4013.33%
Negative yoy deferred tax while CRWD stands at 61.99%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.10%
SBC growth well above CRWD's 13.23%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-25.63%
Both reduce yoy usage, with CRWD at -200.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-137.79%
Both yoy AR lines negative, with CRWD at -124.34%. Martin Whitman would suspect an overall sector lean approach or softer demand.
230.57%
Inventory growth of 230.57% while CRWD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
122.35%
AP growth well above CRWD's 184.01%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
24.39%
Lower 'other working capital' growth vs. CRWD's 100.00%. David Dodd would see fewer unexpected short-term demands on cash.
-8.19%
Negative yoy while CRWD is 14.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-45.51%
Both yoy CFO lines are negative, with CRWD at -13.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
8.09%
Lower CapEx growth vs. CRWD's 64.44%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-103066.67%
Negative yoy acquisition while CRWD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
18.20%
Purchases well above CRWD's 31.64%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
40.80%
We have some liquidation growth while CRWD is negative at -36.63%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
1373.81%
We have some outflow growth while CRWD is negative at -9.26%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
20.14%
Lower net investing outflow yoy vs. CRWD's 52.10%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-1730.22%
We cut debt repayment yoy while CRWD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-45.64%
Both yoy lines negative, with CRWD at -200.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
17.49%
Buyback growth of 17.49% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.